<code id='A9D1AFC501'></code><style id='A9D1AFC501'></style>
    • <acronym id='A9D1AFC501'></acronym>
      <center id='A9D1AFC501'><center id='A9D1AFC501'><tfoot id='A9D1AFC501'></tfoot></center><abbr id='A9D1AFC501'><dir id='A9D1AFC501'><tfoot id='A9D1AFC501'></tfoot><noframes id='A9D1AFC501'>

    • <optgroup id='A9D1AFC501'><strike id='A9D1AFC501'><sup id='A9D1AFC501'></sup></strike><code id='A9D1AFC501'></code></optgroup>
        1. <b id='A9D1AFC501'><label id='A9D1AFC501'><select id='A9D1AFC501'><dt id='A9D1AFC501'><span id='A9D1AFC501'></span></dt></select></label></b><u id='A9D1AFC501'></u>
          <i id='A9D1AFC501'><strike id='A9D1AFC501'><tt id='A9D1AFC501'><pre id='A9D1AFC501'></pre></tt></strike></i>

          focus

          focus

          author:hotspot    Page View:832
          An office building with Kaiser Permanente's logo — hospitals coverage from STAT
          Adobe

          More than a year ago, Kaiser Permanente made waves when it said it was creating a new, sprawling entity of nonprofit hospitals and doctors with Geisinger as its first takeover — the latest example of health care companies bulking up in an already highly consolidated industry.

          Nothing has happened since then, at least publicly. Geisinger’s 10 hospitals and 1,700 employed physicians are now officially part of the group, known as Risant Health. Kaiser, which is both a health insurance company and a network of providers, said it wants to add at least five to six more health systems by 2028.

          advertisement

          Those other organizations are still a mystery. But recent financial reports show a handful of systems that have been on the same shaky trajectory as Geisinger and could find themselves in Kaiser’s crosshairs. Patients and local communities have a lot at stake if their health system gets gobbled up by Kaiser; it’s still unclear how this unique structure will alter costs or quality of care.

          STAT+ Exclusive Story

          Already have an account? Log in

          STAT+

          This article is exclusive to STAT+ subscribers

          Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

          Already have an account? Log in

          Already have an account? Log in

          Monthly

          $39

          Totals $468 per year

          $39/month Get Started

          Totals $468 per year

          Starter

          $30

          for 3 months, then $39/month

          $30 for 3 months Get Started

          Then $39/month

          Annual

          $399

          Save 15%

          $399/year Get Started

          Save 15%

          11+ Users

          Custom

          Savings start at 25%!

          Request A Quote Request A Quote

          Savings start at 25%!

          2-10 Users

          $300

          Annually per user

          $300/year Get Started

          $300 Annually per user

          View All Plans

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more
          Illumina to lay off 10% of research and development team
          Illumina to lay off 10% of research and development team

          AdobeSANDIEGO—Monthsafterannouncingplanstocutcostsby$100million,DNAsequencinggiantIlluminahasbegunto

          read more
          In age of alternative facts, a scholarly course on calling out crap
          In age of alternative facts, a scholarly course on calling out crap

          Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

          read more

          The creative science of coining drug names

          GarethCattermole/GettyImagesCialis,Eliquis,Jevtana,Xgeva.Thesedrugnamesmaysoundsilly,buttheprocessof